Osteoporosis resulting from an imbalance of bone turnover between resorption and
formation is a critical health issue worldwide. Estrogen deficiency following a nature aging …

Glucocorticoid administration is the most common cause of secondary osteoporosis and the
leading cause of nontraumatic osteonecrosis. In patients receiving long-term therapy …

The article presents guidelines for the diagnosis and management of patients with primary
autoimmune haemolytic anaemia (AIHA). Topics discussed include diagnostic approach to …

Systemic glucocorticoids are an essential therapy for a range of conditions, but their multiple
side effects can produce significant morbidity for patients. The objective of this review is to …

Introduction: Severe osteoporosis represents a disease of high mortality and morbidity.
Recognition of what constitutes and causes severe osteoporosis and aggressive …

Glucocorticoids remain a cornerstone of guideline-based management of persistent asthma
and allergic diseases. Glucocorticoid-induced osteoporosis (GIO) is the most common …

Glucocorticoids (GCs) are highly effective in the treatment of inflammatory and autoimmune
conditions but their therapeutic use is limited by numerous adverse effects. Recent insights …

Glucocorticoid-induced osteoporosis is the most frequent form of secondary osteoporosis
caused by chronic exposure to glucocorticoid excess. Pathogenesis of glucocorticoid …

Following the completion of the Fracture Prevention Trial, teriparatide was approved by the
United States Food and Drug Administration and the European Medicine Agency as the first …

Objective To provide an updated review of several causes of secondary osteoporosis as
well as screening recommendations for these disorders. Methods We conducted an updated …